Includes bibliographical references and index.
|Statement||editors, Nicholas Bruchovsky, James H. Goldie.|
|Contributions||Bruchovsky, Nicholas., Goldie, James H.|
|LC Classifications||RC271.C5 D77 1982|
|The Physical Object|
|Pagination||2 v. :|
|ISBN 10||0849365163, 0849365171|
|LC Control Number||82004530|
The book describes the colon cancer as a model for resistance to antineoplastic drugs; mathematical modeling of drug resistance; and the mechanism of induced gene amplification in mammalian cells. The text also discusses the cellular concomitants of multidrug resistance; resistance to alkylating agents; and the phosphoprotein and protein kinase C changes in human multidrug-resistant cancer . This chapter discusses the characteristic features, epidemiology, pathophysiology, clinical features, complications, and management of endocrine-related genetic disorders and diseases such as McCune–Albright syndrome, endocrine tumours in neurofibromatosis type 1, Von Hippel–Lindau disease (VHL), Carney complex, Cowden syndrome, and multiple endocrine neoplasia Author: Helen E. Turner. In: Bruchovsky N, Goldie JH (eds) Drug and hormone resistance in neoplasia, vol I. CRC, Boca Raton, pp – Google Scholar Isaacs JT () The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic by: 3. This chapter discusses clinical features, epidemiology, and management/treatment strategies for resistance to hormones such as thyroid receptor alpha and beta resistance to thyroid hormone (TR-alpha RTH and TR-beta RTH, respectively). It also discusses androgen insensitivity, as in resistance to testosterone and dihydrotestosterone, which can result in complete, partial, and Author: Helen E. Turner.
Hyperthyroidism (secondary to the homology between the beta-subunits of hCG and thyroid-stimulating hormone (TSH), which causes hCG to have weak TSH-like activity). Preeclampsia early in pregnancy. The most common antecedent pregnancy in Author: PDQ Adult Treatment Editorial Board. provides accurate and independent information on more t prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 4 May ), Cerner Multum™ (updated 4 May . About Neoplasia, Estrogen Dependent: Neoplasia is a medical term describing an abnormal mass of tissue (tumor) caused by an abnormal group of rapidly dividing estrogen dependant neoplasia is a type of breast tumor that is dependent on estrogen for growth. Stress creates hormonal responses that cause weight gain and insulin resistance. Cortisol is an adrenal hormone that helps you to run faster, see further, hear better and pump fuel into your bloodstream for quick energy. It is the hormone that helps us survive in the face of true danger. It also shuts down digestion and slows your g: neoplasia.
Title: Evidence for a Putative Relationship Between Type 2 Diabetes and Neoplasia with Particular Reference to Breast Cancer: Role of Hormones, Growth Factors and Specific Receptors VOLUME: 4 ISSUE: 1 Author(s):E. Guastamacchia, F. Resta, V. Triggiani, A. Liso, B. Licchelli, S. Ghiyasaldin, C. Sabba and E. Tafaro Affiliation:Section of Endocrinology and Cited by: Common LHRH drugs include goserelin (Zoladex) and leuprolide (Lupron). They can be used alone or with other hormone drugs (tamoxifen, aromatase inhibitors, fulvestrant) as hormone therapy in pre-menopausal women. Chemotherapy drugs: Some chemo drugs can damage the ovaries of pre-menopausal women so they no longer make estrogen. Ovarian function. In Cancer Drug Resistance, leading scientists from the best academic institutions and industrial laboratories summarize and synthesize the latest discoveries concerning the changes that occur in tumor cells as they develop resistance to a wide variety of anticancer therapeutics, as well as suggest new approaches to the biology of drug Format: Hardcover. Syndromes of Hormone Resistance on the Hypo-thalamic-Pituitary-Thyroid Axis Kluwer Academic Publishers Group, Dordrecht, Netherlands A book in the Endocrine Updates series.